Sort by 'shares'
Racing Toward An Ebola Vaccine, But What About A Cure?
In the absence of a proven cure for EBOLA, researchers across the country are in a frenzy to get the one vaccine which can prevent the spread of this deadly disease and also provide people offering medical care to the…
Evolving Treatment Paradigm of Multiple Myeloma
In the past decade, the FDA has approved 13 new agents and 29 treatments for multiple myeloma, which have transformed the treatment paradigm for patients. The expanded treatment options have resulted in significantly improved outcomes. Two decades ago, the median…
Active Surveillance in Prostate Cancer
One in seven men will be diagnosed with prostate cancer in his lifetime and the likelihood of being diagnosed increases with age. In this show, Active Surveillance expert Dr. Laurence Klotz discusses the value of Active Surveillance as a management…
CLR 131 – A New Approach in Multiple Myeloma Treatment
CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head & neck cancers by Cellectar Biosciences. It works by delivering a radioactive, toxic compound directly to tumor…
Next Generation Targeted Cancer Therapies – The Cellectar Story!
CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions to the fore and informing the patient community. This talk series will be hosted by Gary…